Prospective Analysis of Role of hsTnT and NT-proBNP in Prediction of Neurogenic Stress Cardiomyopathy in Patients with Aneurysmal Subarachnoid Haemorrhage

2021 ◽  
Vol 69 (4) ◽  
pp. 944
Author(s):  
AmitK Sharma ◽  
Daljit Singh ◽  
Bhawna Mahajan ◽  
Monica Tandon ◽  
Hukum Singh
2019 ◽  
Vol 25 (1) ◽  
pp. 44-52
Author(s):  
Lukas Piliponis ◽  
Gintarė Neverauskaitė-Piliponienė ◽  
Monika Kazlauskaitė ◽  
Pavel Kačnov ◽  
Sigita Glaveckaitė ◽  
...  

Summary Neurogenic stress cardiomyopathy (NSC) is defined as transient cardiac dysfunction occurring after primary brain injury, such as aneurysmal subarachnoid haemorrhage, and characterised by left ventricular systolic dysfunction with reduced ejection fraction and abnormalities of regional wall motion. It may also be suspected if elevated levels of cardiac biomarkers and ECG abnormalities are present. It is a reversible condition with favourable long-term prognosis if diagnosed and treated timely, however, NSC is associated with higher rates of early mortality and complications, including pulmonary oedema, cardiogenic shock, delayed cerebral ischaemia. Early diagnosis of the NSC is important in order to prevent these complications and reduce mortality. Management of the NSC is complicated and a multidisciplinary approach is usually required.


2019 ◽  
Vol 94 (6) ◽  
pp. 1897-1917 ◽  
Author(s):  
Shruthi S. Ramesh ◽  
Rita Christopher ◽  
Bhagavatula Indira Devi ◽  
Dhananjaya I. Bhat

Critical Care ◽  
2010 ◽  
Vol 14 (Suppl 1) ◽  
pp. P340
Author(s):  
I Papanikolaou ◽  
M Fragou ◽  
P Zotos ◽  
D Karakitsos ◽  
A Patrianakos ◽  
...  

2002 ◽  
Vol 103 (s2002) ◽  
pp. 399S-403S ◽  
Author(s):  
David K. MENON ◽  
Diana DAY ◽  
Rhoda E. KUC ◽  
Andrew J. DOWNIE ◽  
Doris A. CHATFIELD ◽  
...  

Plasma endothelin (ET) is elevated in patients with vasospasm following subarachnoid haemorrhage (SAH). However, systemic levels provide no indication regarding local production in the brain, and late elevation may be a consequence rather than a cause of vasospasm. We measured arteriojugular (AJ) gradients of ET-1 in 17 patients over the first week after SAH, and related these to the subsequent development of vasospasm. Daily, paired arterial and jugular bulb blood samples were obtained up to seven days post SAH, and assayed for ET-1 using radioimmunoassay. Systemic levels and AJ gradients were compared in patients with and without vasospasm. Significant AJ gradients were observed for ET-1 (P<0.01). These differences remained significant in the subgroup of patients who developed vasospasm (0.12±0.05pmol/l; P<0.05), in whom AJ gradients represented 25±7% of systemic levels (0.84±0.05pmol/l). AJ gradients did not reach significance in patients who did not develop vasospasm (0.09±0.07pmol/l; P = 0.2). Systemic ET-1 levels and AJ gradients were unrelated to SAH grade, surgical or endovascular interventions, or extracranial complications. AJ gradients in the first week following SAH suggest early production of ET-1 in the cerebrovascular bed. However, early systemic ET-1 levels did not discriminate between patients with and without vasospasm. Larger AJ differences may predict vasospasm, but further work is needed to confirm this observation. AJ gradient measurement may provide a useful technique for investigating the role of other peptides in acute brain injury.


Sign in / Sign up

Export Citation Format

Share Document